MELISSA KNUDSEN: Open Payments
NPI 1447096508 · SPRINGFIELD, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$970 in 40 payments from 13 companies in 2025. Trend: 2023 $0 · 2024 $301 · 2025 $970
Food & beverage: $970
| Company | Payments | Amount |
|---|---|---|
| Eisai Inc. | 8 | $300 |
| AstraZeneca Pharmaceuticals LP | 10 | $208 |
| Lilly USA, LLC | 4 | $151 |
| Novo Nordisk Inc | 4 | $63 |
| Abbott Laboratories | 2 | $49 |
| Novartis Pharmaceuticals Corporation | 3 | $46 |
| Otsuka America Pharmaceutical, Inc. | 2 | $34 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $30 |
| Dexcom, Inc. | 1 | $21 |
| Collegium Pharmaceutical, Inc. | 1 | $19 |
Products named: Leqembi, FARXIGA, AMYVID, BREZTRI, Ozempic, FREESTYLE LIBRE, AIRSUPRA, KISUNLA.
Industry payments across MO — which companies pay providers there.
